All > Dementia With Lewy Bodies > Neuroendocrine Tumor

18F-DOPA for Parkinson's Disease

Phase-Based Progress Estimates
2
Effectiveness
3
Safety
Parkinson's Disease+5 More18F-DOPA - Drug
Eligibility
Any Age
All Sexes
What conditions do you have?
Select

Study Summary

This trial is looking at using 18F-DOPA PET/CT imaging in specific patient populations to see if it can help optimize images and identify gallbladder activity patterns.

Eligible Conditions
  • Parkinson's Disease
  • Neuroblastoma
  • Congenital Hyperinsulinism
  • Brain Tumor
  • Neuroendocrine Tumors
  • Lewy Body Disease

Treatment Effectiveness

Effectiveness Progress

2 of 3
This is further along than 85% of similar trials

Similar Trials

1
[18F]FDOPA
1
[18F]P17-059
1
[18F]-αvβ6-BP

Study Objectives

4 Primary · 2 Secondary · Reporting Duration: Within 1 month of PET/CT scan

At the time of enrollment
Gallbladder disease questionnaire
Month 1
Assessment of bladder activity
Assessment of bladder activity artifact
Minimum lesion detectability (SUV)
Minimum lesion detectibility (size)
Month 3
Gallbladder activity pattern

Trial Safety

Safety Progress

3 of 3
This is further along than 85% of similar trials

Similar Trials

1
[18F]FDOPA
1
[18F]P17-059
1
[18F]-αvβ6-BP

Trial Design

1 Treatment Group

18F-DOPA injection
1 of 1

Experimental Treatment

800 Total Participants · 1 Treatment Group

Primary Treatment: 18F-DOPA · No Placebo Group · Phase 3

18F-DOPA injectionExperimental Group · 2 Interventions: Furosemide Injection, 18F-DOPA · Intervention Types: Drug, Drug
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Furosemide
FDA approved
18F-DOPA
2017
Completed Phase 3
~2080

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: within 1 month of pet/ct scan

Who is running the clinical trial?

University of AlbertaLead Sponsor
816 Previous Clinical Trials
375,764 Total Patients Enrolled
Jonathan Abele, MDPrincipal InvestigatorUniversity of Alberta
1 Previous Clinical Trials
600 Total Patients Enrolled

Eligibility Criteria

Age Any Age · All Participants · 5 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
References

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top